DrugPatentWatch Database Preview
Email this page to a colleague» See Plans and Pricing
« Back to Dashboard
Estetrol is an investigational drug.
There have been 20 clinical trials for Estetrol. The most recent clinical trial was a Phase 2 trial, which was initiated on August 1st 2016.
The most common disease conditions in clinical trials are Breast Neoplasms, Prostatic Neoplasms, and Hot Flashes. The leading clinical trial sponsors are Estetra, Pantarhei Bioscience, and Pantarhei Oncology B.V.
There are ninety-five US patents protecting this investigational drug and six hundred and eighty-seven international patents.
Recent Clinical Trials for Estetrol
|Estetrol for the Treatment of Moderate to Severe Vasomotor Symptoms in Postmenopausal Women (E4Comfort Study I)||ICON Clinical Research||Phase 3|
|Estetrol for the Treatment of Moderate to Severe Vasomotor Symptoms in Postmenopausal Women (E4Comfort Study I)||Estetra||Phase 3|
|Estetrol for the Treatment of Moderate to Severe Vasomotor Symptoms in Postmenopausal Women||ICON Clinical Research||Phase 3|
Top disease conditions for Estetrol
Top clinical trial sponsors for Estetrol
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Estetrol||Start Trial||Synthesis of estetrol via estrone derived steroids||Donesta Bioscience B.V. (Zeist, NL)||Start Trial|
|Estetrol||Start Trial||Neuroprotection and myelin repair using Nestorone.RTM.||The Population Council, Inc. (New York, NY)||Start Trial|
|Estetrol||Start Trial||Gene fusions and gene variants associated with cancer||LIFE TECHNOLOGIES CORPORATION (Carlsbad, CA)||Start Trial|
|Estetrol||Start Trial||Controlled release dosage form||TRIASTEK, INC. (Nanjing, CN)||Start Trial|
|Estetrol||Start Trial||Tablet containing dehydroepiandrosterone (DHEA)||PANTARHEI BIOSCIENCE B.V. (Zeist, NL)||Start Trial|
|Estetrol||Start Trial||Apparatus and methods for drug delivery using multiple reservoirs||CLEARSIDE BIOMEDICAL, INC. (Alpharetta, GA)||Start Trial|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|